Extended-release monthly buprenorphine injection

In 2018, Health Canada approved the only BUP-XR treatment available in Canada, under the brand name Sublocade. It is covered by all provinces and territories as part of their public drug plans, primarily for treating moderate-to-severe opioid use disorder. All prescribers across Canada must complete